Mutation analysis of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia

被引:26
作者
Sakurai, K
Toru, M
Yamakawa-Kobayashi, K
Arinami, T [1 ]
机构
[1] Univ Tsukuba, Inst Basic Med Sci, Dept Med Genet, Tsukuba, Ibaraki 3058575, Japan
[2] Tokyo Med & Dent Univ, Sch Med, Dept Neuropsychiat, Tokyo 113, Japan
关键词
N-methyl-D-aspartate receptor NR1 subunit gene; schizophrenia; association; mutation; genome;
D O I
10.1016/S0304-3940(00)01599-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Dysfunction of N-methyl-D-aspartate (NMDA) type ionotropic glutamate receptors has been implicated in the etiology of schizophrenia based on psychotomimetic properties of the antagonist phencyclidine (PCP) and observation that mice expressing low revels of the N-methyl-D-aspartate receptor NR1 subunit exhibit behavioral alterations that may be ameliorated by neuroleptic drugs. Based on the hypothesis that some schizophrenic patients have functionally deficient mutation(s) of the gene encoding N-methyl-D-aspartate receptor NR1 subunit (GRIN1), we screened 48 Japanese patients with schizophrenia for mutations in the coding region of the GRIN1 gene. Four variants, IVS2-22T > C, IVS2-12G > A, IVS4-34C > T, and 1719G/A (Pro516Pro), were identified. No non-synonymous mutation was detected. No significant association was suggested by case-control comparisons. Results indicate that genomic variations of the GRIN1 gene are not likely to be involved substantially in the etiology of schizophrenia. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:168 / 170
页数:3
相关论文
共 23 条
[1]   The NMDA antagonist model for schizophrenia: Promise and pitfalls [J].
Abi-Saab, WM ;
D'Souza, DC ;
Moghaddam, B ;
Krystal, JH .
PHARMACOPSYCHIATRY, 1998, 31 :104-109
[2]  
Bolonna AA, 1999, AM J HUM GENET, V65, pA265
[3]   Characterization of single-nucleotide polymorphisms in coding regions of human genes [J].
Cargill, M ;
Altshuler, D ;
Ireland, J ;
Sklar, P ;
Ardlie, K ;
Patil, N ;
Lane, CR ;
Lim, EP ;
Kalyanaraman, N ;
Nemesh, J ;
Ziaugra, L ;
Friedland, L ;
Rolfe, A ;
Warrington, J ;
Lipshutz, R ;
Daley, GQ ;
Lander, ES .
NATURE GENETICS, 1999, 22 (03) :231-238
[4]   CURRENT METHODS OF MUTATION DETECTION [J].
COTTON, RGH .
MUTATION RESEARCH, 1993, 285 (01) :125-144
[5]   Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A [J].
Das, S ;
Sasaki, YF ;
Rothe, T ;
Premkumar, LS ;
Takasu, M ;
Crandall, JE ;
Dikkes, P ;
Conner, DA ;
Rayudu, PV ;
Cheung, W ;
Chen, HSV ;
Lipton, SA ;
Nakanishi, N .
NATURE, 1998, 393 (6683) :377-381
[6]  
DeLisi LE, 2000, AM J MED GENET, V96, P434, DOI 10.1002/1096-8628(20000612)96:3<434::AID-AJMG40>3.0.CO
[7]  
2-C
[8]  
Ebralidze AK, 1996, J NEUROSCI, V16, P5014
[9]   THE N-METHYL-D-ASPARTATE ANTAGONISTS PHENCYCLIDINE, KETAMINE AND DIZOCILPINE AS BOTH BEHAVIORAL AND ANATOMICAL MODELS OF THE DEMENTIAS [J].
ELLISON, G .
BRAIN RESEARCH REVIEWS, 1995, 20 (02) :250-267
[10]   TARGETED DISRUPTION OF NMDA RECEPTOR-1 GENE ABOLISHES NMDA RESPONSE AND RESULTS IN NEONATAL DEATH [J].
FORREST, D ;
YUZAKI, M ;
SOARES, HD ;
NG, L ;
LUK, DC ;
SHENG, M ;
STEWART, CL ;
MORGAN, JI ;
CONNOR, JA ;
CURRAN, T .
NEURON, 1994, 13 (02) :325-338